News & Updates

Show Multimedia Only

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

29 Sep 2023

Treatment with the oral form of nalbuphine, PHN131, appears to effectively control moderate-to-severe pain in patients who have undergone hemorrhoidectomy, according to a study.

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

29 Sep 2023

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

29 Sep 2023 by

Aldosterone synthase inhibition with lorundrostat confers substantial blood pressure (BP)-lowering benefit in people with uncontrolled hypertension, while having a favourable safety profile, according to data from the phase II Target-HTN trial.

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

29 Sep 2023

Triple drug combo induces endoscopic remission in more than a third of CD patients

29 Sep 2023

In the treatment of Crohn’s disease (CD), the triple combination of vedolizumab, adalimumab, and methotrexate leads to endoscopic remission in 34.5 percent of patients and clinical remission in 54.5 percent, according to data from the phase IV EXPLORER trial.

Triple drug combo induces endoscopic remission in more than a third of CD patients

29 Sep 2023

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

28 Sep 2023

Normal-tension glaucoma (NTG) patients with hypertension who experience morning blood pressure (BP) surge are likely to have visual field progression, as shown in a study.

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

28 Sep 2023

Tacrolimus or cyclosporine for CLAD: The better of 2 immunosuppressants

28 Sep 2023 by

Tacrolimus given once daily significantly reduced the 3-year incidence of chronic lung allograft dysfunction (CLAD) in lung transplant patients compared with standard immunosuppressant in the open label, multicentre, ScanCLAD trial presented at ERS 2023.

Tacrolimus or cyclosporine for CLAD: The better of 2 immunosuppressants

28 Sep 2023

Is it safe to take mefenamic acid with ciprofol?

27 Sep 2023

Mefenamic acid shows no significant interaction with ciprofol in healthy individuals, which suggests that ciprofol is safe and well tolerated when administered along with mefenamic acid, reports a study.

Is it safe to take mefenamic acid with ciprofol?

27 Sep 2023

Drug monitoring may prevent weight gain in ASD patients taking aripiprazole

27 Sep 2023 by

A recent study exploring the relationship between aripiprazole pharmacokinetics (PK), side effects, and effectiveness in children and adolescents with autism spectrum disorder (ASD) has found that higher plasma levels correlate with greater weight gain.

Drug monitoring may prevent weight gain in ASD patients taking aripiprazole

27 Sep 2023

Atezolizumab-chemo confers durable survival benefit in ES-SCLC

27 Sep 2023 by

In the merged analysis of the IMpower133 trial and IMbrella A open-label extension study, the combination of the PD-L1 inhibitor atezolizumab and a chemotherapy regimen comprising carboplatin and etoposide (CP/ET) demonstrated potential for survival benefit of up to 5 years in patients with extensive stage-small-cell lung cancer (ES-SCLC).

Atezolizumab-chemo confers durable survival benefit in ES-SCLC

27 Sep 2023

Liver cirrhosis tied to higher risk of herpes zoster

26 Sep 2023

The risk of herpes zoster (HZ) and HZ-related hospitalization is much higher among patients with liver cirrhosis (LC), especially those who are not currently recommended for HZ vaccination, than the general population, according to a nationwide population-based study in Korea.

Liver cirrhosis tied to higher risk of herpes zoster

26 Sep 2023

Calcium-channel blocker use ups glaucoma prevalence

26 Sep 2023 by

Use of calcium-channel blockers (CCBs) appears to increase the risk of developing glaucoma, suggests a study. In addition, use of systemic beta blockers is associated with lower intraocular pressure (IOP).

Calcium-channel blocker use ups glaucoma prevalence

26 Sep 2023

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

Oral nalbuphine helps control moderate-to-severe pain after hemorrhoidectomy

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

Lorundrostat may expand treatment toolbox for uncontrolled hypertension

Triple drug combo induces endoscopic remission in more than a third of CD patients

Triple drug combo induces endoscopic remission in more than a third of CD patients

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

Morning BP surge predicts visual field progression in glaucoma patients with hypertension

Tacrolimus or cyclosporine for CLAD: The better of 2 immunosuppressants

Tacrolimus or cyclosporine for CLAD: The better of 2 immunosuppressants

Is it safe to take mefenamic acid with ciprofol?

Is it safe to take mefenamic acid with ciprofol?

Drug monitoring may prevent weight gain in ASD patients taking aripiprazole

Drug monitoring may prevent weight gain in ASD patients taking aripiprazole

Atezolizumab-chemo confers durable survival benefit in ES-SCLC

Atezolizumab-chemo confers durable survival benefit in ES-SCLC

Liver cirrhosis tied to higher risk of herpes zoster

Liver cirrhosis tied to higher risk of herpes zoster

Calcium-channel blocker use ups glaucoma prevalence

Calcium-channel blocker use ups glaucoma prevalence